Triamcinolone acetonide and Panic disorder - a phase IV clinical study of FDA data

Summary:

Panic disorder is found among people who take Triamcinolone acetonide, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Triamcinolone acetonide and have Panic disorder. It is created by eHealthMe based on reports of 13,203 people who have side effects when taking Triamcinolone acetonide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 03, 2023

13,203 people reported to have side effects when taking Triamcinolone acetonide.
Among them, 35 people (0.27%) have Panic disorder.

What is Triamcinolone acetonide?

Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is often used in eczema. eHealthMe is studying from 13,324 Triamcinolone acetonide users for its effectiveness, alternative drugs and more.

What is Panic disorder?

Panic disorder is found to be associated with 2,675 drugs and 1,991 conditions by eHealthMe.

Number of Triamcinolone acetonide and Panic disorder reports submitted per year:

Could Triamcinolone acetonide cause Panic disorder?

Gender of people who have Panic disorder when taking Triamcinolone acetonide *:

female: 65.71 %
male: 34.29 %

Age of people who have Panic disorder when taking Triamcinolone acetonide *:

Common drugs people take besides Triamcinolone acetonide *:

Common side effects people have besides Panic disorder *:

Stress And Anxiety: 28 people, 80.00%
Depression: 13 people, 37.14%
Headache (pain in head): 12 people, 34.29%
Nausea (feeling of having an urge to vomit): 12 people, 34.29%
Breathing Difficulty: 11 people, 31.43%
Dizziness: 11 people, 31.43%
Fatigue (feeling of tiredness): 10 people, 28.57%
Pain: 9 people, 25.71%
Nervousness: 9 people, 25.71%
Chest Pain: 8 people, 22.86%

Common conditions people have *:

High Blood Cholesterol: 8 people, 22.86%
Pain: 7 people, 20.00%
Depression: 6 people, 17.14%
High Blood Pressure: 5 people, 14.29%
Pain In Extremity: 5 people, 14.29%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 11.43%
Stress And Anxiety: 4 people, 11.43%
Pneumonia: 3 people, 8.57%
Influenza Like Illness: 3 people, 8.57%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone acetonide and have Panic disorder?

Check whether Panic disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Common Triamcinolone acetonide side effects:

Browse all side effects of Triamcinolone acetonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Panic disorder treatments and more:

Panic disorder (59,765 reports)

COVID vaccines that are related to Panic disorder:

Common drugs associated with Panic disorder:

All the drugs that are associated with Panic disorder:

Panic disorder (2,675 drugs)

Common conditions associated with Panic disorder:

Depression: 4,163 reports
Stress and anxiety: 3,393 reports
Pain: 1,992 reports
Multiple sclerosis: 1,734 reports
High blood pressure: 1,599 reports

All the conditions that are associated with Panic disorder:

Panic disorder (1,991 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Triamcinolone acetonide) and Triamcinolone acetonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.